مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

3,441
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

229
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

INFLUENCE OF INTRAVENOUS HEPARIN THERAPY IN PATIENTS WITH PROGRESSIVE STROKE AND CRESCENDO TRANSIENT ISCHEMIC ATTACKS

Pages

  637-644

Abstract

 Introduction: Progressing stroke (PS) and Crescendo TRANSIENT ISCHEMIC ATTACKS (CTIA) are generally accepted, though unproven, indications for urgent anticoagulation and there remains evidence-free practice of intravenous HEPARIN therapy in these patients.Methods and Materials: Consecutive PS and CTIA patients admitted in Mashhad Ghaem hospital during 2007-2008, enrolled in a prospective observational study. PS and CTIA patients underwent intravenous HEPARIN therapy 1000 units per hour for 3 days without bolus dose. PS and CTIA patients who had a contraindication of intravenous HEPARIN therapy received 80 mg Aspirin per day. Early clinical courses including improvement, stabilization, deterioration and development of residual stroke were evaluated in two therapeutic groups of PS and CTIA patients.Results: 170 PS patients (103 males, 67 females) with mean age 60.4±12.3 years and 88 CTIA patients (50 males, 38 females) with mean age 60.1±6.8 years were investigated. 141 PS and 64 CTIA patients received a short period of intravenous HEPARINization. The distribution of subtypes of early clinical course into two therapeutic groups of PS and CTIA patients was significantly different; X2=10.487, df=2, p=0.005 and X2=6.72, df=2, p=0.035 respectively. Distribution of residual stroke in two therapeutic groups of PS and CTIA patients was not significantly different; X2=1.443, df=1, p=0.23, OR=0.557 (0.212-1.462) and X2=1.01, df=1, p=0.315, OR=0.617 (0.24-1.587) respectively.Conclusion: PS and CTIA patients who received a short period of intravenous HEPARIN therapy have significantly more probability of improvement and less probability of deterioration in their early clinical course.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    GHANDEHARI, K., NIKKHAH, K., BOROUMAND, A.R., HOSSEININEZHAD, S.J., DERAKHSHAN, S., MELAT ARDAKANI, A., & FATAHZADEH, GH.. (2010). INFLUENCE OF INTRAVENOUS HEPARIN THERAPY IN PATIENTS WITH PROGRESSIVE STROKE AND CRESCENDO TRANSIENT ISCHEMIC ATTACKS. CURRENT JOURNAL OF NEUROLOGY (IRANIAN JOURNAL OF NEUROLOGY), 8(28), 637-644. SID. https://sid.ir/paper/102833/en

    Vancouver: Copy

    GHANDEHARI K., NIKKHAH K., BOROUMAND A.R., HOSSEININEZHAD S.J., DERAKHSHAN S., MELAT ARDAKANI A., FATAHZADEH GH.. INFLUENCE OF INTRAVENOUS HEPARIN THERAPY IN PATIENTS WITH PROGRESSIVE STROKE AND CRESCENDO TRANSIENT ISCHEMIC ATTACKS. CURRENT JOURNAL OF NEUROLOGY (IRANIAN JOURNAL OF NEUROLOGY)[Internet]. 2010;8(28):637-644. Available from: https://sid.ir/paper/102833/en

    IEEE: Copy

    K. GHANDEHARI, K. NIKKHAH, A.R. BOROUMAND, S.J. HOSSEININEZHAD, S. DERAKHSHAN, A. MELAT ARDAKANI, and GH. FATAHZADEH, “INFLUENCE OF INTRAVENOUS HEPARIN THERAPY IN PATIENTS WITH PROGRESSIVE STROKE AND CRESCENDO TRANSIENT ISCHEMIC ATTACKS,” CURRENT JOURNAL OF NEUROLOGY (IRANIAN JOURNAL OF NEUROLOGY), vol. 8, no. 28, pp. 637–644, 2010, [Online]. Available: https://sid.ir/paper/102833/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top